{
    "SPADE_UN_11337": {
        "Clinical Information": [
            {
                "Medical use": "Combined with chemotherapy in the first-line treatment of advanced non-small cell lung cancer;Topical treatment in diabetic neutropathic ulcers",
                "Company": "Agennix",
                "Stage of Development": "Phase III",
                "Comments": "The trial met its primary end point and the addition of oral talactoferrin to carboplatin/paclitaxel enhanced the patients response to chemotherapy on all tumour-related end points, including response rate, progression-free survival, time to response and duration of response(p = 0.05)",
                "Clinical Trials": [
                    "NCT00706862",
                    "NCT00707304"
                ]
            }
        ],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11337",
            "Peptide Name": "Talactoferrin alpha(Lactoferroxin-A)",
            "Sequence": "YLGSGY",
            "Source": "Talactoferrin alfa is a novel immunomodulatory 80 kD protein with demonstrated oral anti-tumor properties. Lactoferrin, a protein found in breast milk is developed by Agennix. It increases bodyâ€™s immune power and also works as a natural antioxidant, helping to control cell and tissue damage caused by oxidation.",
            "Target Organism": "No MICs found on DRAMP database",
            "Reference": [
                "Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. (2006).",
                "Oral lactoferrin inhibits growth of established tumours and potentiates conventional chemotherapy. Int. J. Cancer(2004).(PMID:15221967)",
                "Phase I trial of oral talactoferrin alfa in refractory solid tumors.Invest. New Drugs(2006).(PMID:16193240)"
            ],
            "Biological Activity": [
                "Anticancer"
            ],
            "Frequent Amino Acids": "GYL",
            "Absent Amino Acids": "ACDEFHIKMNOPQRTUVW",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 3,
            "Polar Residues": 3,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "Mass": 658.7,
            "PI": 5.52,
            "Net Charge": 0,
            "Hydrophobicity": -0.07,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_00174",
                    "Similarity": 1.0,
                    "Sequence": "GWKSVFRKAKKVGKTVGGLALDHYLG"
                },
                {
                    "SPADE_ID": "SPADE_UN_00175",
                    "Similarity": 1.0,
                    "Sequence": "GWKKWFNRAKKVGKTVGGLAVDHYLG"
                },
                {
                    "SPADE_ID": "SPADE_UN_18658",
                    "Similarity": 1.0,
                    "Sequence": "AIPAVDPFGRVKRSPWHGGTWGCKPIWACQNSPPYLG"
                }
            ]
        }
    }
}